ARTICLE | Company News
Shire gets Reminyl approval in Europe
July 12, 2000 7:00 AM UTC
Shire (LSE:SHP: SHPGY) said Reminyl galantamine to treat Alzheimer's disease has received approval in 13 EU countries. Norway and Iceland have also approved the product. SHP will market the product in...